Could skipping this shot ease chemo pain? new study aims to find out

NCT ID NCT05753618

Recruiting now Symptom relief Sponsor: Ottawa Hospital Research Institute Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times

Summary

This study looks at whether women with early-stage breast cancer can safely skip a drug called G-CSF during one part of their chemotherapy to reduce bone pain. About 242 participants will be randomly assigned to either take or skip the drug while on paclitaxel. The main goal is to see if skipping it lowers pain without raising the risk of serious infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY STAGE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Kingston Health Sciences Centre
RECRUITING

Kingston, Ontario, K7L 2V7, Canada
Lakeridge Health
RECRUITING

Oshawa, Ontario, L1G 2B9, Canada
The Ottawa Hospital Cancer Centre
RECRUITING

Ottawa, Ontario, K1H 8L6, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

EARLY STAGE BREAST CANCER